Medications

Broad-spectrum malaria vaccine developed

Griffith University researchers are a step closer in the fight against malaria with the development of a broad-spectrum vaccine that can be freeze-dried making it suitable for deployment into malaria-endemic countries.

Diseases, Conditions, Syndromes

Monoclonal antibody prevents malaria in small NIH trial

One dose of a new monoclonal antibody discovered and developed at the National Institutes of Health safely prevented malaria for up to nine months in people who were exposed to the malaria parasite. The small, carefully monitored ...

Diseases, Conditions, Syndromes

New insights into immune responses to malaria

Advanced technologies have been used to solve a long-standing mystery about why some people develop serious illness when they are infected with the malaria parasite, while others carry the infection asymptomatically.

Diseases, Conditions, Syndromes

Blocking how the malaria parasite suppresses the immune response

The parasites that cause severe malaria are well-known for the sinister ways they infect humans, but new research may lead to drugs that could block one of their most reliable weapons: interference with the immune response.

page 5 from 40